People · Operator
Named in public records as an officer, director or promoter · active 2021–2026 · Pharma, Other Technology, Healthtech, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cognito Therapeutics Group, Inc. | — | Pharma | Series D+ | $196.3M | $1.7B | 2025 |
| Cognito Therapeutics Ltd. | — | Pharma | Series D+ | $119.0M | $111.6M | 2022 |
| MedRhythms, Inc. | — | Other Technology | Series B | $58.9M | $13.8M | 2021 |
| Palo Alto Health Sciences, Inc. | — | Healthtech | Series B | $49.6M | $166.0M | 2024 |
| Convexity Scientific Inc. | — | Other Health Care | Series B | $37.8M | $2.4M | 2021 |
| AdaptX, Inc. | — | Other Technology | Series A | $21.0M | $9.0M | 2025 |
| Simplifed, Inc. | — | Other | Series A | $10.8M | $94.4M | 2022 |
| Origin Medical Systems, Inc. | — | Healthtech | Series A | $7.2M | $1.8M | 2023 |
| Curve Health, Inc. | — | Healthtech | Seed | $3.9M | $23.6M | 2023 |
Stephen Bruso at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Bruso on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.